| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2023 | 276.97% | Ascendiant Capital | → $3.3 | Initiates Coverage On | → Buy |
| 12/19/2022 | 242.7% | Maxim Group | $8 → $3 | Maintains | Buy |
| 11/09/2022 | 813.87% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 08/08/2022 | 813.87% | Benchmark | → $8 | Initiates Coverage On | → Speculative Buy |
What is the target price for Heart Test Laboratories (HSCS)?
The latest price target for Heart Test Laboratories (NASDAQ: HSCS) was reported by Ascendiant Capital on January 30, 2023. The analyst firm set a price target for $3.30 expecting HSCS to rise to within 12 months (a possible 276.97% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Heart Test Laboratories (HSCS)?
The latest analyst rating for Heart Test Laboratories (NASDAQ: HSCS) was provided by Ascendiant Capital, and Heart Test Laboratories initiated their buy rating.
When is the next analyst rating going to be posted or updated for Heart Test Laboratories (HSCS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heart Test Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heart Test Laboratories was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
Is the Analyst Rating Heart Test Laboratories (HSCS) correct?
While ratings are subjective and will change, the latest Heart Test Laboratories (HSCS) rating was a initiated with a price target of $0.00 to $3.30. The current price Heart Test Laboratories (HSCS) is trading at is $0.88, which is within the analyst's predicted range.
